US Patent Issued to DEUTSCHES KREBSFORSCHUNG-SZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG on May 20 for "RNA viruses for immunovirotherapy" (German, Canadian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,540, issued on May 20, was assigned to DEUTSCHES KREBSFORSCHUNG-SZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (Heidelberg, Germany).

"RNA viruses for immunovirotherapy" was invented by Christine Engeland (Heidelberg, Germany), Guy Ungerechts (Heidelberg, Germany) and Sascha Bossow (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a recombinant virus of the family Paramyxoviridae, comprising at least one expressible polynucleotide encoding a secreted activator of the immune response, to a polynucleotide encoding the same, and to a kit comprising the same. Moreover, the present invention relates to a method for ...